TC Medical(SH:600763) Sou Hu Cai Jing·2025-10-22 20:52Core Insights - Tongce Medical (600763) reported a slight decline in stock price, closing at 42.2 yuan, with a trading volume of 31,600 shares and a total transaction value of 134 million yuan on October 22, 2025 [1] Trading Information Summary - On October 22, 2025, the net outflow of main funds was 929,100 yuan, accounting for 0.69% of the total transaction value; retail investors had a net inflow of 3.21 million yuan, representing 2.4% of the total transaction value [1][3] Company Announcement Summary - Tongce Medical held a semi-annual performance briefing on October 22, 2025, reporting the following key financial metrics for the first half of 2025: - Outpatient visits reached 1.7322 million, a year-on-year increase of 1.21% - Revenue was 1.448 billion yuan, up 2.68% year-on-year - Net profit attributable to shareholders was 321 million yuan, reflecting a 3.67% increase year-on-year - Net profit excluding non-recurring items was 317 million yuan, with a year-on-year growth of 3.9% - Operating cash flow net amount was 355 million yuan, up 9.7% year-on-year - Medical service revenue in Zhejiang Province was 1.22 billion yuan, a 2.6% increase year-on-year - Gross margin was 40.75%, and net margin was 26.26% - Orthodontics business grew by 7.75%, while pediatric services accounted for 17.6% of total revenue - Revenue from Loudi Dental Hospital increased by 7% year-on-year - The company has completed supply chain integration, leading to a continuous decrease in material costs - A new branch in Shanghai is expected to open by the end of the year, with plans to establish five new branches in 2025 - High labor costs are being managed through the development of a physician training program and improved diagnostic efficiency [1]